Page last updated: 2024-08-05 10:51:42

tryptamines

Tryptamine and its substitution derivatives.

ChEBI ID: 27162

Members (34)

MemberDefinitionRole
2-methyl-5-ht2-methylserotonin
3-(1H-indol-3-yl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]propanamide3-(1H-indol-3-yl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]propanamide
5-(nonyloxy)tryptamineA tryptamine derivative that consists of serotonin bearing an additional O-nonyl substituent. 5-HT1B selective agonist, several times more potent than sumatriptan and inactive as a 5-HT1A agonist (Ki at 5-HT1B = 1 nM, selectivity over 5-HT1A > 300-fold).5-nonyloxytryptamine
5-carboxamidotryptamine5-carboxamidotryptamine
5-methoxy-alpha-methyltryptamine1-(5-methoxy-1H-indol-3-yl)-2-propanamine
5-methoxy-n,n-diisopropyltryptamine5-methoxy-N,N-diisopropyltryptamine
5-methoxytryptamineA member of the class of tryptamines that is the methyl ether derivative of serotonin.5-methoxytryptamine
5-methyltryptamine2-(5-methyl-1H-indol-3-yl)ethanamine
6-hydroxyindoramin6-Hydroxyindoramin
6-hydroxymelatoninA member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6.6-hydroxymelatonin
alpha-methylserotoninalpha-methylserotonin
avitriptanavitriptan
bw 723c861-[5-(thiophen-2-ylmethoxy)-1H-indol-3-yl]-2-propanamine
deformylflustrabromineDesformylflustrabromine
gr 1598975-fluoro-3-[2-[4-methoxy-4-[[(R)-phenylsulfinyl]methyl]-1-piperidinyl]ethyl]-1H-indole
indopanA tryptamine derivative having a methyl substituent at the alpha-position.alpha-methyltryptamine
indoraminindoramin
l 694247N-[4-[[5-[3-(2-aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl]methyl]phenyl]methanesulfonamide
melatoninA member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans.melatonin
n-(2-(5-methoxy-2-oxo-2,3-dihydro-1h-indol-3-yl)ethyl)acetamideA member of the class of hydroxyindoles that is melatonin in which the hydrogen at position 2 of the indole ring has been replaced by a hydroxy group. A predominant hydroxylated melatonin metabolite in plants.2-hydroxymelatonin
N-ethyl-3-(1H-indol-3-yl)-N-[2-oxo-2-(thiophen-2-ylmethylamino)ethyl]propanamideN-ethyl-3-(1H-indol-3-yl)-N-[2-oxo-2-(thiophen-2-ylmethylamino)ethyl]propanamide
N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamideN-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamide
N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamideN-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide
n-methylserotoninA member of the class of tryptamines that is serotonin in which one of the hydrogens attached to the primary amino group is replaced by a methyl group.N-methylserotonin
n-methyltryptamineN-methyltryptamine
n,n-diallyl-5-methoxytryptamine1h-indole-3-ethanamine, 5-methoxy-n,n-di-2-propen-1-yl-
n,n-diisopropyltryptamineN,N-diisopropyltryptamine
n,n-dimethyltryptamineA tryptamine derivative having two N-methyl substituents on the side-chain.N,N-dimethyltryptamine
naratriptannaratriptan
rizatriptanrizatriptan
Serotonin hydrochlorideSerotonin hydrochloride
sumatriptanA sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.sumatriptan
tryptamineAn aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position.tryptamine
zolmitriptanA member of the class of tryptamines that is N,N-dimethyltryptamine in which the hydrogen at position 5 of the indole ring has been replaced by a [(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl group. A serotonin 5-HT1 B and D receptor agonist, it is used for the treatment of migraine.zolmitriptan

Research

Studies (27,486)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19903,696 (13.45)18.7374
1990's5,322 (19.36)18.2507
2000's7,050 (25.65)29.6817
2010's7,587 (27.60)24.3611
2020's3,831 (13.94)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials2,286 (7.56%)5.53%
Reviews4,351 (14.39%)6.00%
Case Studies652 (2.16%)4.05%
Observational64 (0.21%)0.25%
Other22,873 (75.67%)84.16%